Detection of Epidermal Growth Factor Receptor (EGFR) Mutations in Circulating Cell-Free DNA in Two Phase III Studies (LUX-Lung 3 and LUX-Lung 6) of Afatinib vs Platinum-Based Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

    American Journal of Clinical Pathology, 2014.

    Cited by: 0|Bibtex|Views1|

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments